Eleven Biotherapeutics (EBIO) PT Raised to $8 at Leerink Partners

August 13, 2015 2:13 PM

Leerink Partners analyst Jason Gerberry reiterated an Outperform rating and boosted his price target on Eleven Biotherapeutics (NASDAQ: EBIO) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found